tiprankstipranks
Advertisement
Advertisement

Sysmex Details Progress on ¥30 Billion Share Buyback Program

Story Highlights
  • Sysmex has begun executing a board-approved share buyback program to optimize its capital structure and support shareholder value.
  • From March 6 to 31, 2026, Sysmex repurchased 1,695,300 shares for about ¥2.33 billion, with ample capacity remaining under its ¥30 billion authorization.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Sysmex Details Progress on ¥30 Billion Share Buyback Program

Claim 30% Off TipRanks

An announcement from Sysmex ( (JP:6869) ) is now available.

Sysmex Corporation has disclosed the progress of its ongoing share buyback program, conducted under Japan’s Companies Act, as it continues to repurchase its own common stock on the Tokyo Stock Exchange. The initiative is part of a previously approved board authorization designed to optimize capital structure and potentially enhance shareholder value through reduced share count.

Between March 6 and March 31, 2026, Sysmex acquired 1,695,300 shares of its common stock for a total of ¥2,326,864,528 via market purchases. This buyback represents an initial portion of a larger program authorizing the repurchase of up to 30 million shares, or roughly 4.81% of shares outstanding excluding treasury stock, with a maximum total outlay of ¥30 billion through September 18, 2026.

The current pace of repurchases indicates Sysmex is in the early stages of utilizing its full buyback capacity, leaving substantial room for further purchases over the coming months. For investors, the continued execution of this program could support earnings per share and signal management’s confidence in the company’s long-term prospects, while also underscoring a shareholder-return focus within Japan’s diagnostics and medical technology sector.

The most recent analyst rating on (JP:6869) stock is a Buy with a Yen1505.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.

More about Sysmex

Sysmex Corporation is a Japanese healthcare company specializing in diagnostic instruments, reagents, and related software, with a core focus on in vitro diagnostics and hematology testing systems. The company is listed on the Tokyo Stock Exchange and targets hospital, clinical laboratory, and life science markets globally through advanced testing and analysis solutions.

Average Trading Volume: 4,465,765

Technical Sentiment Signal: Sell

Current Market Cap: Yen853.4B

See more insights into 6869 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1